Welcome to LookChem.com Sign In|Join Free

CAS

  • or

950651-11-3

Post Buying Request

950651-11-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

950651-11-3 Usage

Class

Acetamide

Molecular Structure

Contains an amino group (-NH2), a phenyl group with a trifluoromethoxy substituent (-OCH3), and an acetamide functional group (-CONH2)

Applications

Used in medicinal chemistry for synthesizing pharmaceuticals
Utilized in research and development in organic chemistry

Properties

Functional Groups: Contains an amino group, a phenyl group with a trifluoromethoxy substituent, and an acetamide functional group
Biological Activity: Its unique structure makes it a valuable building block for creating biologically active molecules and drugs

Significance

Important compound in the pharmaceutical industry for drug development and synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 950651-11-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,0,6,5 and 1 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 950651-11:
(8*9)+(7*5)+(6*0)+(5*6)+(4*5)+(3*1)+(2*1)+(1*1)=163
163 % 10 = 3
So 950651-11-3 is a valid CAS Registry Number.

950651-11-3Relevant articles and documents

NITROGENATED HETEROCYCLIC COMPOUND

-

, (2015/03/28)

The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

COMPOUNDS WHICH INHIBIT THE GLYCINE TRANSPORTER AND USES THEREOF

-

Page/Page column 37, (2008/06/13)

Compounds of formula (I) and salts and solvates thereof are provided: wherein R1 to R8 and n are defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicament for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder are also disclosed. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 950651-11-3